Revisión sistemática de la literatura sobre el beneficio de tamización para infección asintomática por SARS-Cov-2 en pacientes con neoplasia hemato- oncológica candidatos a terapia con quimioterapia

ilustraciones, gráficas, tablas

Autores:: Caro Flautero, María Alejandra
Acevedo Medina, Carlos Alberto

Tipo de recurso:

Fecha de publicación:: 2021

Institución:: Universidad Nacional de Colombia

Repositorio:: Universidad Nacional de Colombia

Idioma:: spa

id	UNACIONAL2_584a0b7071c665be76266cba93fbd466
oai_identifier_str	oai:repositorio.unal.edu.co:unal/80985
network_acronym_str	UNACIONAL2
network_name_str	Universidad Nacional de Colombia
repository_id_str
dc.title.spa.fl_str_mv	Revisión sistemática de la literatura sobre el beneficio de tamización para infección asintomática por SARS-Cov-2 en pacientes con neoplasia hemato- oncológica candidatos a terapia con quimioterapia
dc.title.translated.eng.fl_str_mv	Benefit of screening for asymptomatic SARS-Cov-2 infection in patients with hemato-oncological neoplasia who are candidates for chemotherapy therapy: A Systematic review
title	Revisión sistemática de la literatura sobre el beneficio de tamización para infección asintomática por SARS-Cov-2 en pacientes con neoplasia hemato- oncológica candidatos a terapia con quimioterapia
spellingShingle	Revisión sistemática de la literatura sobre el beneficio de tamización para infección asintomática por SARS-Cov-2 en pacientes con neoplasia hemato- oncológica candidatos a terapia con quimioterapia 610 - Medicina y salud::616 - Enfermedades Drug Therapy Coronavirus Infections/diagnosis Review Quimioterapia Infecciones por Coronavirus/diagnóstico Revisión Neoplasms SARS-CoV-2 Consolidation chemotherapy Maintenance chemotherapy Mass screening Real-time polymerase chain reaction COVID-19 testing Neoplasia Quimioterapia Tamización Reacción en cadena de la polimerasa en tiempo real
title_short	Revisión sistemática de la literatura sobre el beneficio de tamización para infección asintomática por SARS-Cov-2 en pacientes con neoplasia hemato- oncológica candidatos a terapia con quimioterapia
title_full	Revisión sistemática de la literatura sobre el beneficio de tamización para infección asintomática por SARS-Cov-2 en pacientes con neoplasia hemato- oncológica candidatos a terapia con quimioterapia
title_fullStr	Revisión sistemática de la literatura sobre el beneficio de tamización para infección asintomática por SARS-Cov-2 en pacientes con neoplasia hemato- oncológica candidatos a terapia con quimioterapia
title_full_unstemmed	Revisión sistemática de la literatura sobre el beneficio de tamización para infección asintomática por SARS-Cov-2 en pacientes con neoplasia hemato- oncológica candidatos a terapia con quimioterapia
title_sort	Revisión sistemática de la literatura sobre el beneficio de tamización para infección asintomática por SARS-Cov-2 en pacientes con neoplasia hemato- oncológica candidatos a terapia con quimioterapia
dc.creator.fl_str_mv	Caro Flautero, María Alejandra Acevedo Medina, Carlos Alberto
dc.contributor.advisor.spa.fl_str_mv	Saavedra Trujillo, Carlos Humberto
dc.contributor.author.spa.fl_str_mv	Caro Flautero, María Alejandra Acevedo Medina, Carlos Alberto
dc.subject.ddc.spa.fl_str_mv	610 - Medicina y salud::616 - Enfermedades
topic	610 - Medicina y salud::616 - Enfermedades Drug Therapy Coronavirus Infections/diagnosis Review Quimioterapia Infecciones por Coronavirus/diagnóstico Revisión Neoplasms SARS-CoV-2 Consolidation chemotherapy Maintenance chemotherapy Mass screening Real-time polymerase chain reaction COVID-19 testing Neoplasia Quimioterapia Tamización Reacción en cadena de la polimerasa en tiempo real
dc.subject.decs.eng.fl_str_mv	Drug Therapy Coronavirus Infections/diagnosis Review
dc.subject.decs.spa.fl_str_mv	Quimioterapia Infecciones por Coronavirus/diagnóstico Revisión
dc.subject.proposal.eng.fl_str_mv	Neoplasms SARS-CoV-2 Consolidation chemotherapy Maintenance chemotherapy Mass screening Real-time polymerase chain reaction COVID-19 testing
dc.subject.proposal.spa.fl_str_mv	Neoplasia Quimioterapia Tamización Reacción en cadena de la polimerasa en tiempo real
description	ilustraciones, gráficas, tablas
publishDate	2021
dc.date.issued.none.fl_str_mv	2021
dc.date.accessioned.none.fl_str_mv	2022-02-15T15:06:32Z
dc.date.available.none.fl_str_mv	2022-02-15T15:06:32Z
dc.type.spa.fl_str_mv	Trabajo de grado - Especialidad Médica
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/masterThesis
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/acceptedVersion
dc.type.content.spa.fl_str_mv	Text
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/TM
status_str	acceptedVersion
dc.identifier.uri.none.fl_str_mv	https://repositorio.unal.edu.co/handle/unal/80985
dc.identifier.instname.spa.fl_str_mv	Universidad Nacional de Colombia
dc.identifier.reponame.spa.fl_str_mv	Repositorio Institucional Universidad Nacional de Colombia
dc.identifier.repourl.spa.fl_str_mv	https://repositorio.unal.edu.co/
url	https://repositorio.unal.edu.co/handle/unal/80985 https://repositorio.unal.edu.co/
identifier_str_mv	Universidad Nacional de Colombia Repositorio Institucional Universidad Nacional de Colombia
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.indexed.spa.fl_str_mv	Bireme
dc.relation.references.spa.fl_str_mv	Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157–60. Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020;18(10):2127–33. Ludwig S, Zarbock A. Coronaviruses and SARS-CoV-2: A Brief Overview. Anesth Analg. 2020;131(1):93–6. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis [Internet]. 2020;20(5):533–4. Available from: http://dx.doi.org/10.1016/S1473-3099(20)30120-1 Globocan. Cifras y estimaciones de cáncer en el mundo. Instituto Nacional de Cancerología, Colombia. Glob Cancer Obs [Internet]. 2018;380:2204. Available from: https://gco.iarc.fr/today/data/factsheets/populations/170-colombia-fact-sheets.pdf Jackson J, Weiss M, Schwarzenberg A, Nelson R. Global Economic Effects of COVID-19. Congr Res Serv [Internet]. 2020;(20):78. Available from: https://crsreports.congress.gov Ioannidis JPA. Infection fatality rate of COVID-19 inferred from seroprevalence data. Bull World Health Organ. 2021;99(1):19-33F. Asociacion colombiana de infectologia. consenso colombiano de atención, diagnóstico y manejo de la infección por sars Cov-2 / covid 19 en establecimientos de atencion de la salud. J Chem Inf Model. 1970;53(9):1689–99. Saavedra Trujillo CH. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;24(3):1. Dhama K, Patel SK, Pathak M, Yatoo MI, Tiwari R, Malik YS, et al. An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Med Infect Dis [Internet]. 2020;37(May):101755. Available from: https://doi.org/10.1016/j.tmaid.2020.101755 Dhungana HN. Comments on “Preliminary estimation of the basic reproduction number of novel Coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven Analysis in the early phase of the outbreak.” Int J Infect Dis. 2020;94:72–3. Zhao Z, Bai H, Duan JC, Wang J. [Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease epidemic]. Zhonghua Zhong Liu Za Zhi [Internet]. 2020;42(0):E007. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32125130 Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol [Internet]. 2020;222(5):415–26. Available from: https://doi.org/10.1016/j.ajog.2020.02.017 Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. RESEARCH High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020;26(7):1470–7. Zhang M, Xiao J, Deng A, Zhang Y, Zhuang Y, Hu T, et al. Transmission Dynamics of an Outbreak of the COVID-19 Delta Variant B.1.617.2 — Guangdong Province, China, May–June 2021. China CDC Wkly. 2021;3(27):584–6. Earnest R, Uddin R, Matluk N, Renzette N, Siddle KJ, Loreth C, et al. Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA. medRxiv Prepr Serv Heal Sci [Internet]. 2021;2021. Available from: http://www.ncbi.nlm.nih.gov/pubmed/34642698%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC8509091 Shaw CL, Kennedy DA. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information . 2020;(January). Yu CJ, Wang ZX, Xu Y, Hu MX, Chen K, Qin G. Assessment of basic reproductive number for COVID-19 at global level: A meta-analysis. Medicine (Baltimore). 2021;100(18):e25837. Vigilancia D De. Respiratoria Aguda Y La Enfermedad Asociada Al Nuevo Coronavirus 2019. 2020; Gaythorpe K, Imai N, Cuomo-dannenburg G, Baguelin M, Bhatia S, Boonyasiri A, et al. Symptom progression of COVID-19. Imp Coll London COVID-19 Response Team. 2020;(11 March):1–10. Lin S, Kantor R, Clark E. Coronavirus Disease 2019. Clin Geriatr Med. 2021;37(4):509–22. Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133(9):1032–8. Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA - J Am Med Assoc. 2020;323(13):1239–42. Tinoco-garcía A. definition of Cancer : Scientific Controversy between the Orthodox Paradigm and Critical Paradigm. 2019;19(38):11–52. Al‐Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 ( COVID ‐19) Pandemic: An International Collaborative Group . Oncologist. 2020;25(6):936–45. Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol [Internet]. 2020; Available from: http://www.ncbi.nlm.nih.gov/pubmed/32139904 Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020;2019:1648–55. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. Crankson S, Pokhrel S, Anokye NK. Determinants of COVID-19 outcomes: A systematic review. medRxiv [Internet]. 2021;2021.03.21.21254068. Available from: http://medrxiv.org/content/early/2021/03/23/2021.03.21.21254068.abstract Hu C, Li J, Xing X, Gao J, Zhao S, Xing L. The effect of age on the clinical and immune characteristics of critically ill patients with COVID-19: A preliminary report. PLoS One [Internet]. 2021;16(3 March):1–11. Available from: http://dx.doi.org/10.1371/journal.pone.0248675 de Oliveira Maier SR, Rodrigues JPF, Sudré MRS, Dessotte CAM. Cardiac complications in patients with COVID-19: An integrative literature review. Aquichan. 2020;20(4):1–13. Addeo A, Friedlaender A. Cancer and COVID-19: Unmasking their ties. Cancer Treat Rev. 2020;88(May). Hsu SH, Wang S. The debate in Hospice Care. J Oncol Pract. 2008;4(3):153–7. Brissot E, Labopin M, Baron F, Bazarbachi A, Bug G, Ciceri F, et al. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant [Internet]. 2021;56(3):532–5. Available from: http://dx.doi.org/10.1038/s41409-020-0970-x Garassino MC, Whisenant JG, Huang LC, Trama A, Torri V, Agustoni F, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020;21(7):914–22. Joanna Briggs Institute. The Joanna Briggs Institute Scientific Writer Handbook. 2018;29. Greenhalgh T. How to read a paper. Papers that report diagnostic or screening tests. Br Med J. 1997;315(7107):540–3. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons; 2019. Morphology TC. No 主観的健康感を中心とした在宅高齢者における健康関連指標に関する共分散構造分析Title. Carro Pérez E. Características básicas y utilidad del metaanálisis en las ciencias del comportamiento. Rev Psicol y Ciencias del Comport la Unidad Académica Ciencias Jurídicas y Soc. 2013;4(2):47–66. Al-Shamsi HO, Coomes EA, Aldhaheri K, Alrawi S. Serial Screening for COVID-19 in Asymptomatic Patients Receiving Anticancer Therapy in the United Arab Emirates. JAMA Oncol. 2021 Jan;7(1):129–31. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19. Aging (Albany NY). 2020;12(7):6049–57. Williams M, Le Calvez K, Mi E, Chen J, Dadhania S, Pakzad-Shahabi L. Estimating the Risks from COVID-19 Infection in Adult Chemotherapy Patients. medRxiv [Internet]. 2020;2:2020.03.18.20038067. Available from: http://medrxiv.org/content/early/2020/03/20/2020.03.18.20038067.abstract Basile C, Combe C, Pizzarelli F, Covic A, Davenport A, Kanbay M, et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant. 2020;35(5):737–41. Jee J, Foote MB, Lumish M, Stonestrom AJ, Wills B, Narendra V, et al. Chemotherapy and COVID-19 Outcomes in Patients With Cancer. J Clin Oncol [Internet]. 2020 Aug 14;38(30):3538–46. Available from: https://doi.org/10.1200/JCO.20.01307 Garciá-Suárez J, De La Cruz J, Cedillo Á, Llamas P, Duarte R, Jiménez-Yuste V, et al. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: Lessons from a large population-based registry study. J Hematol Oncol. 2020;13(1):1–12. Scarfò L, Chatzikonstantinou T, Rigolin GM, Quaresmini G, Motta M, Vitale C, et al. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. Leukemia. 2020;34(9):2354–63. de Melo AC, Thuler LCS, da Silva JL, de Albuquerque LZ, Pecego AC, Rodrigues L de OR, et al. Cancer inpatients with COVID-19: A report from the Brazilian National Cancer Institute. PLoS One. 2020;15(10):e0241261. Fong D, Rauch S, Petter C, Haspinger E, Alber M, Mitterer M. Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy. ESMO Open. 2020 Jan;5(3). Haradaa G, Antonacio FF, Gongora AB, Behar MH, Capareli FC, Bastos DA, et al. SARS-CoV-2 testing for asymptomatic adult cancer patients before initiating systemic treatments: a systematic review. Ecancermedicalscience. 2020;14:1100. D’Aiello A, Zareef S, Pradhan K, Lombardo A, Khatun F, Mustafa J, et al. Older Age and Increased Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms and COVID-19 Patients. Blood. 2020 Nov;136(Supplement 1):34–5. Angelis V, Tippu Z, Joshi K, Reis S, Gronthoud F, Fribbens C, et al. Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer. Eur J Cancer [Internet]. 2020;136:99–106. Available from: https://doi.org/10.1016/j.ejca.2020.06.027 Alhuraiji A, Eldadah S, Alfraih F, Pandita R, Absi A, Hanbali A, et al. Optimal Management of Acute Lymphoblastic Leukemia (ALL) in Adult Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic. Gulf J Oncolog. 2020 Apr;1(33):7–18. Ramaswamy A, Nayak L, Roy Moulik N, Sengar M, Chinnaswamy G, Jobanputra K, et al. COVID-19 in cancer patients on active systemic therapy – Outcomes from LMIC scenario with an emphasis on need for active treatment. Cancer Med. 2020;9(23):8747–53. Ramesh A, Ssoundarajan R. Abstract PO-008: Cancer care during the COVID-19 pandemic in Southern India. Clin Cancer Res. 2020 Sep;26(18 Supplement):PO-008 LP-PO-008. Infante MS, González-Gascón y Marín I, Muñoz-Novas C, Churruca J, Foncillas MÁ, Landete E, et al. COVID-19 in patients with hematological malignancies: A retrospective case series. Int J Lab Hematol. 2020;42(6):e256–9. Niu A, Ning B, Socola F, Safah H, Reynolds T, Ibrahim M, et al. COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality. Blood. 2020 Nov;136(Supplement 1):6–7. Al Saleh AS, Sher T, Gertz MA. Multiple Myeloma in the Time of COVID-19. Acta Haematol. 2020;143(5):410–6. Albiges L, Foulon S, Bayle A, Gachot B, Pommeret F, Willekens C, et al. Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort. Nat Cancer [Internet]. 2020;1(10):965–75. Available from: http://dx.doi.org/10.1038/s43018-020-00120-5 Lee LYW, Hill T, Topping O, Tilby M, Baker M, Greig J, et al. Utility of COVID-19 Screening in Cancer Patients. Cancer Cell. 2020;38(3):306–7. Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, Fattizzo B, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020 Dec;136(25):2881–92. Ismael J, Losco F, Quildrian S, Sanchez P, Pincemin I, Lastiri J, et al. Multidisciplinary approach to COVID-19 and cancer: consensus from scientific societies in Argentina. Vol. 14, Ecancermedicalscience. 2020. p. 1044. Malard F, Genthon A, Brissot E, van de Wyngaert Z, Marjanovic Z, Ikhlef S, et al. COVID-19 outcomes in patients with hematologic disease. Bone Marrow Transplant [Internet]. 2020;55(11):2180–4. Available from: http://dx.doi.org/10.1038/s41409-020-0931-4 Lee LYW, Cazier JB, Angelis V, Arnold R, Bisht V, Campton NA, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: A prospective cohort study. Lancet. 2020;395(10241):1919–26. Brar G, Pinheiro LC, Shusterman M, Swed B, Reshetnyak E, Soroka O, et al. COVID-19 severity and outcomes in patients with cancer: A matched cohort study. J Clin Oncol. 2020;38(33):3914–24. Yekedüz E, Utkan G, Ürün Y. A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19. Eur J Cancer. 2020;141:92–104. Phillips L, Pavisic J, Kaur D, Valerio Dorrello N, Broglie L, Hijiya N. Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia. Blood Adv. 2020;4(18):4358–61. Sehn LH, Kuruvilla P, Christofides A, Stakiw J. Management of chronic lymphocytic leukemia in canada during the coronavirus pandemic. Curr Oncol. 2020;27(3):e332–5. Arpino G, De Angelis C, De Placido P, Pietroluongo E, Formisano L, Bianco R, et al. Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era. ESMO open. 2020;5(5):1–6. Ghandili S, Pfefferle S, Roedl K, Sonnemann P, Karagiannis P, Boenisch O, et al. Challenges in treatment of patients with acute leukemia and COVID-19: A series of 12 patients. Blood Adv. 2020;4(23):5936–41. Wilde L, Isidori A, Keiffer G, Palmisiano N, Kasner M. Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience. Front Oncol. 2020;10(September):1–7. Al-Shamsi HO, Coomes EA, Alrawi S. Screening for COVID-19 in Asymptomatic Patients With Cancer in a Hospital in the United Arab Emirates. JAMA Oncol. 2020 Oct;6(10):1627–8. Valenza F, Papagni G, Marchianò A, Daidone MG, DeBraud F, Colombo MP, et al. Response of a comprehensive cancer center to the COVID-19 pandemic: the experience of the Fondazione IRCCS-Istituto Nazionale dei Tumori di Milano. Tumori. 2020 May;300891620923790. Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncol. 2020 Jul;6(7):1108–10. Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020 Jun;25(6):e936–45. Boulad F, Kamboj M, Bouvier N, Mauguen A, Kung AL. COVID-19 in Children With Cancer in New York City. JAMA Oncol. 2020 Sep;6(9):1459–60. He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020 May;26(5):672–5. Madariaga A, McMullen M, Sheikh S, Kumar R, Liu FF, Zimmermann C, et al. COVID-19 Testing in Patients with Cancer: Does One Size Fit All? Clin Cancer Res. 2020;26(18):4737–42. Rans C. Asymptomatic screening for COVID-19 in cancer patients still debated. Hematol Oncol [Internet]. 2021;(May 2020):19–21. Available from: https://www.mdedge.com/hematology-oncology/article/235688/patient-survivor-care/asymptomatic-screening-covid-19-cancer Shaya JA, Cabal A, Torriani F, Califano J, Lippman S, Sacco A, et al. Abstract S09-04: Asymptomatic detection of COVID-19 among cancer patients receiving infusional anti-cancer therapy. 2021;21:S09-04-S09-04. Anil I, Arnold R, Benkwitz-Beford S, Branford S, Campton N, Cazier J-B, et al. The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19. Lancet Oncol. 2020 May;21(5):622–4. Shah MA, Mayer S, Emlen F, Sholle E, Christos P, Cushing M, et al. Clinical Screening for COVID-19 in Asymptomatic Patients With Cancer. JAMA Netw open. 2020;3(9):e2023121. Yekedüz E, Utkan G, Ürün Y. Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle? J Oncol Pharm Pract. 2021;27(2):450–2. Yin P, Zeng R, Duan YR, Zhang Y, Kuang XN, Zhang HF, et al. An analysis of cancer patients with asymptomatic infection of SARS-CoV-2 in a cancer center in Wuhan, China. Ann Oncol. 2020;31(10):1420–2. Alhalabi O, Iyer S, Subbiah V. Testing for COVID-19 in patients with cancer. EClinicalMedicine [Internet]. 2020;23:100374. Available from: https://doi.org/10.1016/j.eclinm.2020.100374 Ürün Y, Hussain SA, Bakouny Z, Castellano D, Kılıçkap S, Morgan G, et al. Survey of the Impact of COVID-19 on Oncologists’ Decision Making in Cancer. JCO Glob Oncol. 2020 Aug;6:1248–57. Passaro A, Peters S, Mok TSK, Attili I, Mitsudomi T, de Marinis F. Testing for COVID-19 in lung cancer patients. Ann Oncol [Internet]. 2020;31(7):832–4. Available from: https://doi.org/10.1016/j.annonc.2020.04.002 Bi J, Ma H, Zhang D, Huang J, Yang D, Wang Y, et al. Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection? Vol. 56, The European respiratory journal. 2020. Slater H. Findings Support Screening of COVID-19 in Patients with Cancer. Cancer Network. 2020.
dc.rights.coar.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.license.spa.fl_str_mv	Atribución-SinDerivadas 4.0 Internacional
dc.rights.uri.spa.fl_str_mv	http://creativecommons.org/licenses/by-nd/4.0/
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
rights_invalid_str_mv	Atribución-SinDerivadas 4.0 Internacional http://creativecommons.org/licenses/by-nd/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.extent.spa.fl_str_mv	43, 27 páginas
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Universidad Nacional de Colombia
dc.publisher.program.spa.fl_str_mv	Bogotá - Medicina - Especialidad en Infectología
dc.publisher.department.spa.fl_str_mv	Departamento de Medicina Interna
dc.publisher.faculty.spa.fl_str_mv	Facultad de Medicina
dc.publisher.place.spa.fl_str_mv	Bogotá, Colombia
dc.publisher.branch.spa.fl_str_mv	Universidad Nacional de Colombia - Sede Bogotá
institution	Universidad Nacional de Colombia
bitstream.url.fl_str_mv	https://repositorio.unal.edu.co/bitstream/unal/80985/4/1018432919.2021.pdf https://repositorio.unal.edu.co/bitstream/unal/80985/5/license.txt https://repositorio.unal.edu.co/bitstream/unal/80985/6/Licencia%20y%20autorizaci%c3%b3n%20para%20publicaci%c3%b3n%20de%20obras%20en%20el%20repositorio%20institucional%20UN%20v4.pdf https://repositorio.unal.edu.co/bitstream/unal/80985/7/1018432919.2021.pdf.jpg
bitstream.checksum.fl_str_mv	f28f0af78f301a17bc9ca0573c48904b 8153f7789df02f0a4c9e079953658ab2 7c58b9024815cd2547fc38204fef0a1a 2b487b3508816de7564e857b76ec82c2
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5 MD5
repository.name.fl_str_mv	Repositorio Institucional Universidad Nacional de Colombia
repository.mail.fl_str_mv	repositorio_nal@unal.edu.co
_version_	1814089791086526464
spelling	Atribución-SinDerivadas 4.0 Internacionalhttp://creativecommons.org/licenses/by-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Saavedra Trujillo, Carlos Humberto08c609ca0fa0817e557a78e527acaa4fCaro Flautero, María Alejandra8016b5a3b1d326c77417b582ce940bc8600Acevedo Medina, Carlos Alberto40f4e53b7d6a1d38c5eff544424eed4a2022-02-15T15:06:32Z2022-02-15T15:06:32Z2021https://repositorio.unal.edu.co/handle/unal/80985Universidad Nacional de ColombiaRepositorio Institucional Universidad Nacional de Colombiahttps://repositorio.unal.edu.co/ilustraciones, gráficas, tablasIntroducción: La enfermedad por Coronavirus 2019 afecta especialmente a los pacientes inmunocomprometidos hemato-oncológicos, no solo por la historia natural de la infección viral, sino por la necesidad de reprogramar o suspender tratamientos inicialmente considerados para el control de su enfermedad de base. Esta población, con necesidad de ciclos de inicio, consolidación o mantenimiento de quimioterapia, ve impactada su calidad de vida y pronostico al no obtener a tiempo este tipo de estrategias terapéuticas. Materiales y métodos: Se realizó una revisión sistemática de la literatura. Se consultaron las bases de datos Medline vía Pubmed, Embase, Cochrane Library of Clinical Trials, Proquest Central y HINARI, a través de términos MeSH, Entry y términos libres. Entre febrero 01 de 2020 y el 14 de mayo de 2021. La tamización y selección de la evidencia se realizó por dos revisores independientes y los desacuerdos se resolvieron por consenso entre ambos. Se incluyeron estudios en inglés y español. La calidad de la evidencia fue evaluada con la herramienta de Joanna Briggs. Los hallazgos se presentan a manera de síntesis narrativa. Resultados: En total se tamizaron 487 documentos a título y resumen, y 47 documentos se revisaron a texto completo para verificar los criterios de elegibilidad. Solo un estudio fue incluido: Un programa de cribado para infección asintomática por SARS-CoV-2 en pacientes cáncer en órgano sólido en un hospital de Arabia Saudita. De 25 pacientes con tamización positiva , 28% requirieron hospitalización, el 8% requirió cuidados avanzados en la unidad de cuidados intensivos, el 88% tuvo retraso en la terapia contra el cáncer y el 12% fallecieron. La mediana del tiempo de retraso de la terapia fue de 16 días. Discusion: Teniendo en cuenta el contexto actual, limitado por la novedad que representa el diagnóstico y tratamiento de esta enfermedad, esta revisión, basada en un solo estudio incluído, sugiere que el cribado para COVID-19 podría representar un beneficio mayor al riesgo para los pacientes, permitiendo tomar medidas sobre el momento oportuno de aplicación de quimioterapia que impacten sobre morbimortalidad; todo esto teniendo en cuenta un escenario de toma de decisión basada en incertidumbre y la aplicación de los principios éticos de beneficencia y no maleficencia. (Texto tomado de la fuente).Background: In December 2019 several cases of atypical and severe viral pneumonia were documented in Wuhan, China, and a couple of weeks after this, the local and global spread increased to the point of being imperative the declaration of a pandemic by the WHO in March 11, 2020 (1). Immunocompromised patients (due to neoplastic pathology or not) have been particularly affected, not only by the natural history of the viral infection, but also by the need to reschedule or suspend treatments initially considered for the control of their underlying disease. Such is the case of patients with hematological and solid organ neoplasms. This population, who needs chemotherapy initiation, consolidation, or maintenance cycles, sees their quality of life and prognosis impacted by not obtaining these types of therapeutic strategies on time. Objective: To recognize the benefit of screening for asymptomatic SARS- Cov-2 infection in a patient with hemato-oncological pathology who is a candidate for systemic treatment with chemotherapy. Methodology: A systematic review of the literature was carried out. The Medline databases were consulted via Pubmed, Embase, Cochrane Library of Clinical Trials, Proquest Central and HINARI, using MeSH, Entry and free terms between February 01, 2020 and May 14, 2021. The screening and selection of the evidence was carried out by two independent reviewers and disagreements were resolved by consensus between the two. Studies in English and Spanish were included. The quality of the evidence was assessed with the Joanna Briggs tool. The findings are presented as a narrative synthesis. Results In total, 487 documents were screened for title and abstract, and 47 documents were reviewed in full text to verify the eligibility criteria. At the end, only one study was included, which documented a screening program for SARS-CoV-2 infection, carried out in asymptomatic patients diagnosed with solid organ cancer in a hospital in Saudi Arabia, 48 hours before the cycle of weekly chemotherapy, daily radiation therapy or chemoradiotherapy, and monthly for hormone therapy. Of 25 patients included in the study, 28% required hospitalization, 8% required advanced care in the intensive care unit, 88% had delayed cancer therapy, and 12% died. The median delay time of therapy was 16 days. Conclusion: Although currently, screening for SARS-CoV-2 infection is an increasingly accepted practice in specialized cancer centers and is widely recommended by clinical experts, this review concludes that there is currently insufficient evidence to determine the effect of screening for infection SARS-Cov-2 in hemato-oncological patients on mortality outcomes, disease progression and requirement for mechanical ventilation. New studies are required and this review may be updated in light of the new evidence.Incluye anexosEspecialidades MédicasEspecialista en Infectología43, 27 páginasapplication/pdfspaUniversidad Nacional de ColombiaBogotá - Medicina - Especialidad en InfectologíaDepartamento de Medicina InternaFacultad de MedicinaBogotá, ColombiaUniversidad Nacional de Colombia - Sede Bogotá610 - Medicina y salud::616 - EnfermedadesDrug TherapyCoronavirus Infections/diagnosisReviewQuimioterapiaInfecciones por Coronavirus/diagnósticoRevisiónNeoplasmsSARS-CoV-2Consolidation chemotherapyMaintenance chemotherapyMass screeningReal-time polymerase chain reactionCOVID-19 testingNeoplasiaQuimioterapiaTamizaciónReacción en cadena de la polimerasa en tiempo realRevisión sistemática de la literatura sobre el beneficio de tamización para infección asintomática por SARS-Cov-2 en pacientes con neoplasia hemato- oncológica candidatos a terapia con quimioterapiaBenefit of screening for asymptomatic SARS-Cov-2 infection in patients with hemato-oncological neoplasia who are candidates for chemotherapy therapy: A Systematic reviewTrabajo de grado - Especialidad Médicainfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/acceptedVersionTexthttp://purl.org/redcol/resource_type/TMBiremeCucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157–60.Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020;18(10):2127–33.Ludwig S, Zarbock A. Coronaviruses and SARS-CoV-2: A Brief Overview. Anesth Analg. 2020;131(1):93–6.Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis [Internet]. 2020;20(5):533–4. Available from: http://dx.doi.org/10.1016/S1473-3099(20)30120-1Globocan. Cifras y estimaciones de cáncer en el mundo. Instituto Nacional de Cancerología, Colombia. Glob Cancer Obs [Internet]. 2018;380:2204. Available from: https://gco.iarc.fr/today/data/factsheets/populations/170-colombia-fact-sheets.pdfJackson J, Weiss M, Schwarzenberg A, Nelson R. Global Economic Effects of COVID-19. Congr Res Serv [Internet]. 2020;(20):78. Available from: https://crsreports.congress.govIoannidis JPA. Infection fatality rate of COVID-19 inferred from seroprevalence data. Bull World Health Organ. 2021;99(1):19-33F.Asociacion colombiana de infectologia. consenso colombiano de atención, diagnóstico y manejo de la infección por sars Cov-2 / covid 19 en establecimientos de atencion de la salud. J Chem Inf Model. 1970;53(9):1689–99.Saavedra Trujillo CH. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;24(3):1.Dhama K, Patel SK, Pathak M, Yatoo MI, Tiwari R, Malik YS, et al. An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Med Infect Dis [Internet]. 2020;37(May):101755. Available from: https://doi.org/10.1016/j.tmaid.2020.101755Dhungana HN. Comments on “Preliminary estimation of the basic reproduction number of novel Coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven Analysis in the early phase of the outbreak.” Int J Infect Dis. 2020;94:72–3.Zhao Z, Bai H, Duan JC, Wang J. [Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease epidemic]. Zhonghua Zhong Liu Za Zhi [Internet]. 2020;42(0):E007. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32125130Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol [Internet]. 2020;222(5):415–26. Available from: https://doi.org/10.1016/j.ajog.2020.02.017Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. RESEARCH High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020;26(7):1470–7.Zhang M, Xiao J, Deng A, Zhang Y, Zhuang Y, Hu T, et al. Transmission Dynamics of an Outbreak of the COVID-19 Delta Variant B.1.617.2 — Guangdong Province, China, May–June 2021. China CDC Wkly. 2021;3(27):584–6.Earnest R, Uddin R, Matluk N, Renzette N, Siddle KJ, Loreth C, et al. Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA. medRxiv Prepr Serv Heal Sci [Internet]. 2021;2021. Available from: http://www.ncbi.nlm.nih.gov/pubmed/34642698%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC8509091Shaw CL, Kennedy DA. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information . 2020;(January).Yu CJ, Wang ZX, Xu Y, Hu MX, Chen K, Qin G. Assessment of basic reproductive number for COVID-19 at global level: A meta-analysis. Medicine (Baltimore). 2021;100(18):e25837.Vigilancia D De. Respiratoria Aguda Y La Enfermedad Asociada Al Nuevo Coronavirus 2019. 2020;Gaythorpe K, Imai N, Cuomo-dannenburg G, Baguelin M, Bhatia S, Boonyasiri A, et al. Symptom progression of COVID-19. Imp Coll London COVID-19 Response Team. 2020;(11 March):1–10.Lin S, Kantor R, Clark E. Coronavirus Disease 2019. Clin Geriatr Med. 2021;37(4):509–22.Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133(9):1032–8.Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA - J Am Med Assoc. 2020;323(13):1239–42.Tinoco-garcía A. definition of Cancer : Scientific Controversy between the Orthodox Paradigm and Critical Paradigm. 2019;19(38):11–52.Al‐Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 ( COVID ‐19) Pandemic: An International Collaborative Group . Oncologist. 2020;25(6):936–45.Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol [Internet]. 2020; Available from: http://www.ncbi.nlm.nih.gov/pubmed/32139904Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020;2019:1648–55.Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62.Crankson S, Pokhrel S, Anokye NK. Determinants of COVID-19 outcomes: A systematic review. medRxiv [Internet]. 2021;2021.03.21.21254068. Available from: http://medrxiv.org/content/early/2021/03/23/2021.03.21.21254068.abstractHu C, Li J, Xing X, Gao J, Zhao S, Xing L. The effect of age on the clinical and immune characteristics of critically ill patients with COVID-19: A preliminary report. PLoS One [Internet]. 2021;16(3 March):1–11. Available from: http://dx.doi.org/10.1371/journal.pone.0248675de Oliveira Maier SR, Rodrigues JPF, Sudré MRS, Dessotte CAM. Cardiac complications in patients with COVID-19: An integrative literature review. Aquichan. 2020;20(4):1–13.Addeo A, Friedlaender A. Cancer and COVID-19: Unmasking their ties. Cancer Treat Rev. 2020;88(May).Hsu SH, Wang S. The debate in Hospice Care. J Oncol Pract. 2008;4(3):153–7.Brissot E, Labopin M, Baron F, Bazarbachi A, Bug G, Ciceri F, et al. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant [Internet]. 2021;56(3):532–5. Available from: http://dx.doi.org/10.1038/s41409-020-0970-xGarassino MC, Whisenant JG, Huang LC, Trama A, Torri V, Agustoni F, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020;21(7):914–22.Joanna Briggs Institute. The Joanna Briggs Institute Scientific Writer Handbook. 2018;29.Greenhalgh T. How to read a paper. Papers that report diagnostic or screening tests. Br Med J. 1997;315(7107):540–3.Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons; 2019.Morphology TC. No 主観的健康感を中心とした在宅高齢者における健康関連指標に関する共分散構造分析Title.Carro Pérez E. Características básicas y utilidad del metaanálisis en las ciencias del comportamiento. Rev Psicol y Ciencias del Comport la Unidad Académica Ciencias Jurídicas y Soc. 2013;4(2):47–66.Al-Shamsi HO, Coomes EA, Aldhaheri K, Alrawi S. Serial Screening for COVID-19 in Asymptomatic Patients Receiving Anticancer Therapy in the United Arab Emirates. JAMA Oncol. 2021 Jan;7(1):129–31.Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19. Aging (Albany NY). 2020;12(7):6049–57.Williams M, Le Calvez K, Mi E, Chen J, Dadhania S, Pakzad-Shahabi L. Estimating the Risks from COVID-19 Infection in Adult Chemotherapy Patients. medRxiv [Internet]. 2020;2:2020.03.18.20038067. Available from: http://medrxiv.org/content/early/2020/03/20/2020.03.18.20038067.abstractBasile C, Combe C, Pizzarelli F, Covic A, Davenport A, Kanbay M, et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant. 2020;35(5):737–41.Jee J, Foote MB, Lumish M, Stonestrom AJ, Wills B, Narendra V, et al. Chemotherapy and COVID-19 Outcomes in Patients With Cancer. J Clin Oncol [Internet]. 2020 Aug 14;38(30):3538–46. Available from: https://doi.org/10.1200/JCO.20.01307Garciá-Suárez J, De La Cruz J, Cedillo Á, Llamas P, Duarte R, Jiménez-Yuste V, et al. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: Lessons from a large population-based registry study. J Hematol Oncol. 2020;13(1):1–12.Scarfò L, Chatzikonstantinou T, Rigolin GM, Quaresmini G, Motta M, Vitale C, et al. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. Leukemia. 2020;34(9):2354–63.de Melo AC, Thuler LCS, da Silva JL, de Albuquerque LZ, Pecego AC, Rodrigues L de OR, et al. Cancer inpatients with COVID-19: A report from the Brazilian National Cancer Institute. PLoS One. 2020;15(10):e0241261.Fong D, Rauch S, Petter C, Haspinger E, Alber M, Mitterer M. Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy. ESMO Open. 2020 Jan;5(3).Haradaa G, Antonacio FF, Gongora AB, Behar MH, Capareli FC, Bastos DA, et al. SARS-CoV-2 testing for asymptomatic adult cancer patients before initiating systemic treatments: a systematic review. Ecancermedicalscience. 2020;14:1100.D’Aiello A, Zareef S, Pradhan K, Lombardo A, Khatun F, Mustafa J, et al. Older Age and Increased Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms and COVID-19 Patients. Blood. 2020 Nov;136(Supplement 1):34–5.Angelis V, Tippu Z, Joshi K, Reis S, Gronthoud F, Fribbens C, et al. Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer. Eur J Cancer [Internet]. 2020;136:99–106. Available from: https://doi.org/10.1016/j.ejca.2020.06.027Alhuraiji A, Eldadah S, Alfraih F, Pandita R, Absi A, Hanbali A, et al. Optimal Management of Acute Lymphoblastic Leukemia (ALL) in Adult Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic. Gulf J Oncolog. 2020 Apr;1(33):7–18.Ramaswamy A, Nayak L, Roy Moulik N, Sengar M, Chinnaswamy G, Jobanputra K, et al. COVID-19 in cancer patients on active systemic therapy – Outcomes from LMIC scenario with an emphasis on need for active treatment. Cancer Med. 2020;9(23):8747–53.Ramesh A, Ssoundarajan R. Abstract PO-008: Cancer care during the COVID-19 pandemic in Southern India. Clin Cancer Res. 2020 Sep;26(18 Supplement):PO-008 LP-PO-008.Infante MS, González-Gascón y Marín I, Muñoz-Novas C, Churruca J, Foncillas MÁ, Landete E, et al. COVID-19 in patients with hematological malignancies: A retrospective case series. Int J Lab Hematol. 2020;42(6):e256–9.Niu A, Ning B, Socola F, Safah H, Reynolds T, Ibrahim M, et al. COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality. Blood. 2020 Nov;136(Supplement 1):6–7.Al Saleh AS, Sher T, Gertz MA. Multiple Myeloma in the Time of COVID-19. Acta Haematol. 2020;143(5):410–6.Albiges L, Foulon S, Bayle A, Gachot B, Pommeret F, Willekens C, et al. Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort. Nat Cancer [Internet]. 2020;1(10):965–75. Available from: http://dx.doi.org/10.1038/s43018-020-00120-5Lee LYW, Hill T, Topping O, Tilby M, Baker M, Greig J, et al. Utility of COVID-19 Screening in Cancer Patients. Cancer Cell. 2020;38(3):306–7.Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, Fattizzo B, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020 Dec;136(25):2881–92.Ismael J, Losco F, Quildrian S, Sanchez P, Pincemin I, Lastiri J, et al. Multidisciplinary approach to COVID-19 and cancer: consensus from scientific societies in Argentina. Vol. 14, Ecancermedicalscience. 2020. p. 1044.Malard F, Genthon A, Brissot E, van de Wyngaert Z, Marjanovic Z, Ikhlef S, et al. COVID-19 outcomes in patients with hematologic disease. Bone Marrow Transplant [Internet]. 2020;55(11):2180–4. Available from: http://dx.doi.org/10.1038/s41409-020-0931-4Lee LYW, Cazier JB, Angelis V, Arnold R, Bisht V, Campton NA, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: A prospective cohort study. Lancet. 2020;395(10241):1919–26.Brar G, Pinheiro LC, Shusterman M, Swed B, Reshetnyak E, Soroka O, et al. COVID-19 severity and outcomes in patients with cancer: A matched cohort study. J Clin Oncol. 2020;38(33):3914–24.Yekedüz E, Utkan G, Ürün Y. A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19. Eur J Cancer. 2020;141:92–104.Phillips L, Pavisic J, Kaur D, Valerio Dorrello N, Broglie L, Hijiya N. Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia. Blood Adv. 2020;4(18):4358–61.Sehn LH, Kuruvilla P, Christofides A, Stakiw J. Management of chronic lymphocytic leukemia in canada during the coronavirus pandemic. Curr Oncol. 2020;27(3):e332–5.Arpino G, De Angelis C, De Placido P, Pietroluongo E, Formisano L, Bianco R, et al. Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era. ESMO open. 2020;5(5):1–6.Ghandili S, Pfefferle S, Roedl K, Sonnemann P, Karagiannis P, Boenisch O, et al. Challenges in treatment of patients with acute leukemia and COVID-19: A series of 12 patients. Blood Adv. 2020;4(23):5936–41.Wilde L, Isidori A, Keiffer G, Palmisiano N, Kasner M. Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience. Front Oncol. 2020;10(September):1–7.Al-Shamsi HO, Coomes EA, Alrawi S. Screening for COVID-19 in Asymptomatic Patients With Cancer in a Hospital in the United Arab Emirates. JAMA Oncol. 2020 Oct;6(10):1627–8.Valenza F, Papagni G, Marchianò A, Daidone MG, DeBraud F, Colombo MP, et al. Response of a comprehensive cancer center to the COVID-19 pandemic: the experience of the Fondazione IRCCS-Istituto Nazionale dei Tumori di Milano. Tumori. 2020 May;300891620923790.Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncol. 2020 Jul;6(7):1108–10.Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020 Jun;25(6):e936–45.Boulad F, Kamboj M, Bouvier N, Mauguen A, Kung AL. COVID-19 in Children With Cancer in New York City. JAMA Oncol. 2020 Sep;6(9):1459–60.He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020 May;26(5):672–5.Madariaga A, McMullen M, Sheikh S, Kumar R, Liu FF, Zimmermann C, et al. COVID-19 Testing in Patients with Cancer: Does One Size Fit All? Clin Cancer Res. 2020;26(18):4737–42.Rans C. Asymptomatic screening for COVID-19 in cancer patients still debated. Hematol Oncol [Internet]. 2021;(May 2020):19–21. Available from: https://www.mdedge.com/hematology-oncology/article/235688/patient-survivor-care/asymptomatic-screening-covid-19-cancerShaya JA, Cabal A, Torriani F, Califano J, Lippman S, Sacco A, et al. Abstract S09-04: Asymptomatic detection of COVID-19 among cancer patients receiving infusional anti-cancer therapy. 2021;21:S09-04-S09-04.Anil I, Arnold R, Benkwitz-Beford S, Branford S, Campton N, Cazier J-B, et al. The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19. Lancet Oncol. 2020 May;21(5):622–4.Shah MA, Mayer S, Emlen F, Sholle E, Christos P, Cushing M, et al. Clinical Screening for COVID-19 in Asymptomatic Patients With Cancer. JAMA Netw open. 2020;3(9):e2023121.Yekedüz E, Utkan G, Ürün Y. Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle? J Oncol Pharm Pract. 2021;27(2):450–2.Yin P, Zeng R, Duan YR, Zhang Y, Kuang XN, Zhang HF, et al. An analysis of cancer patients with asymptomatic infection of SARS-CoV-2 in a cancer center in Wuhan, China. Ann Oncol. 2020;31(10):1420–2.Alhalabi O, Iyer S, Subbiah V. Testing for COVID-19 in patients with cancer. EClinicalMedicine [Internet]. 2020;23:100374. Available from: https://doi.org/10.1016/j.eclinm.2020.100374Ürün Y, Hussain SA, Bakouny Z, Castellano D, Kılıçkap S, Morgan G, et al. Survey of the Impact of COVID-19 on Oncologists’ Decision Making in Cancer. JCO Glob Oncol. 2020 Aug;6:1248–57.Passaro A, Peters S, Mok TSK, Attili I, Mitsudomi T, de Marinis F. Testing for COVID-19 in lung cancer patients. Ann Oncol [Internet]. 2020;31(7):832–4. Available from: https://doi.org/10.1016/j.annonc.2020.04.002Bi J, Ma H, Zhang D, Huang J, Yang D, Wang Y, et al. Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection? Vol. 56, The European respiratory journal. 2020.Slater H. Findings Support Screening of COVID-19 in Patients with Cancer. Cancer Network. 2020.Público generalORIGINAL1018432919.2021.pdf1018432919.2021.pdfTesis de Especialidad en Infectologíaapplication/pdf554976https://repositorio.unal.edu.co/bitstream/unal/80985/4/1018432919.2021.pdff28f0af78f301a17bc9ca0573c48904bMD54LICENSElicense.txtlicense.txttext/plain; charset=utf-84074https://repositorio.unal.edu.co/bitstream/unal/80985/5/license.txt8153f7789df02f0a4c9e079953658ab2MD55Licencia y autorización para publicación de obras en el repositorio institucional UN v4.pdfLicencia y autorización para publicación de obras en el repositorio institucional UN v4.pdfapplication/pdf162496https://repositorio.unal.edu.co/bitstream/unal/80985/6/Licencia%20y%20autorizaci%c3%b3n%20para%20publicaci%c3%b3n%20de%20obras%20en%20el%20repositorio%20institucional%20UN%20v4.pdf7c58b9024815cd2547fc38204fef0a1aMD56THUMBNAIL1018432919.2021.pdf.jpg1018432919.2021.pdf.jpgGenerated Thumbnailimage/jpeg5439https://repositorio.unal.edu.co/bitstream/unal/80985/7/1018432919.2021.pdf.jpg2b487b3508816de7564e857b76ec82c2MD57unal/80985oai:repositorio.unal.edu.co:unal/809852023-08-01 23:03:46.634Repositorio Institucional Universidad Nacional de Colombiarepositorio_nal@unal.edu.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

Revisión sistemática de la literatura sobre el beneficio de tamización para infección asintomática por SARS-Cov-2 en pacientes con neoplasia hemato- oncológica candidatos a terapia con quimioterapia

Publicaciones similares